Average Co-Inventor Count = 2.50
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ludwig Institute for Cancer Research Limited (15 from 525 patents)
15 patents:
1. 9200047 - SSX-2 peptides presented by HLA class II molecules
2. 8008464 - SSX-4 peptides presented by HLA class II molecules
3. 7989587 - SSX-2 peptides presented by HLA class II molecules
4. 7910696 - Ssx-2 peptides presented by hla class II molecules
5. 7858743 - SSX-4 peptides presented by HLA class II molecules
6. 7713714 - Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
7. 7429639 - SSX-2 peptides presented by HLA class II molecules
8. 7344879 - Isolated nucleic acid molecules which encode peptides that bind to HLA molecules, and uses thereof
9. 6605711 - NY-ESO-1 peptide derivatives, and uses thereof
10. 6417165 - NY-ESO-1-peptide derivatives, and uses thereof
11. 6384190 - Isolated decapeptides which bind to HLA molecules
12. 6368857 - Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules
13. 6326200 - Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof
14. 6277956 - Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
15. 6025470 - Isolated nona- and decapeptides which bind to HLA molecules, and the use